Key facts
- It has raised $1.0M; the latest was Seed Round ($1.0M) in Jan 2026.
- Notable investors include Neuro Investment Group.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for neuropacs
- ·The full record, as it builds
Funding rounds
No funding rounds for neuropacs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About neuropacs
Developer of an AI-based imaging software suite designed to detect, analyze, and measure changes associated with neurodegenerative diseases. The company's platform offers imaging analysis tools, proprietary algorithms, and compatibility with existing imaging workflows, enabling clinicians and clinical researchers to support diagnosis and evaluate disease progression in research and clinical settings.
- Sector
- Healthcare
- HQ
- Gainesville, FL, United States
- Founded
- 2021
- Employees
- 7
- Website
- neuropacs.com/
- Ownership
- Privately Held (backing)
neuropacs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in neuropacs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on neuropacs in its N-PORT filings yet. We sweep new filings monthly.